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Elevated levels of stress and anxiety often accompany vestibular dysfunction, while con-
versely complaints of dizziness and loss of balance are common in patients with panic and
other anxiety disorders.The interactions between stress and vestibular function have been
investigated both in animal models and in clinical studies. Evidence from animal studies indi-
cates that vestibular symptoms are effective in activating the stress axis, and that the acute
stress response is important in promoting compensatory synaptic and neuronal plasticity
in the vestibular system and cerebellum.The role of stress in human vestibular disorders is
complex, and definitive evidence is lacking. This article reviews the evidence from animal
and clinical studies with a focus on the effects of stress on the central vestibular pathways
and their role in the pathogenesis and management of human vestibular disorders.
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Stress may influence central vestibular function in health and dis-
ease either directly through the actions of glucocorticoids (cortisol
and corticosterone) on ion channels and neurotransmission in the
brain, or indirectly through the effects of stress-related neuroactive
substances (e.g., histamine, neurosteroids) on these structures. In
the periphery stress hormones also regulate the function of ion
transporters and ionic homeostasis in the inner ear, while in some
conditions the anti-inflammatory actions of glucocorticoids may
also come into play (Hamid et al., 2009). Stress hormones may thus
modulate peripheral vestibular end-organ and cochlear function
through similar mechanisms of ionic homeostasis (Canlon et al.,
2007; Hamid et al., 2009), and modulate central processing in the
vestibular and auditory pathways (Seemungal et al., 2001; Paterson
et al., 2004; Straka et al., 2005; Mazurek et al., 2010).
While inner ear lesions often lead to vestibular and auditory
deficits in parallel, the extent to which lesions in one system
contribute to functional loss and adaptation in the other is at
present largely unknown. For example, auditory cues are known to
contribute to spatial orientation and balance function in sighted
as well as congenitally blind people (Easton et al., 1998; Dozza
et al., 2007), and thus auditory loss may be expected to exacerbate
vestibular dysfunction. However, although stress influences both
the vestibular and auditory systems the mechanisms of plasticity
in the central pathways and the interactions between them remain
to be systematically investigated.
In relation to vestibular lesions and central vestibular com-
pensation, evidence from animal studies has demonstrated neural
pathways linking the vestibular nuclei with the limbic system
including the hypothalamus and that stress responses evoked by
vestibular symptoms promote synaptic and neuronal plasticity
in the vestibular system. However in man conclusive evidence
relating to the interactions between stress and vestibular system
plasticity is lacking. In patients who remain poorly compensated
following vestibular damage, clinical evidence implicates stress
both as a causative agent and as a compounding factor that
impedes compensation. In parallel the use of steroids in the treat-
ment of acute vestibular symptoms also indicates a role for the
acute stress response in facilitating vestibular compensation. Fac-
tors that tend to constrain a fuller understanding of the effects
of stress in human vestibular disease include sometimes nebulous
clinical definitions, difficult to measure endpoints whether clini-
cal or physiological, and variations in the stress response between
individuals and within the same individual over time. Neverthe-
less, the effects of stress on vestibular function and compensation
are significant and increasingly recognized as important in the
management of vestibular dysfunction in man.
STRESS AND VESTIBULAR COMPENSATION IN ANIMAL
STUDIES
NEUROANATOMICAL PATHWAYS
The stress response is complex and involves a number of chemical
mediators including neuropeptides, steroid, and monoamine hor-
mones (Joels and Baram, 2009). The canonical stress response is
mediated by the hypothalamic–pituitary–adrenal (HPA) axis. Cor-
ticotrophin releasing hormone (CRH) and arginine vasopressin
(AVP) in the paraventricular nucleus (PVN) of the hypothalamus
stimulate the release of adrenocorticotropic hormone (ACTH)
from the pituitary, which then causes the release of glucocorticoids
from the adrenal cortex (Herman et al., 2003).
The vestibular system has been shown to have connections with
the HPA axis (Figure 1). Electrical and caloric stimulation of the
vestibular pathways results in a response in PVN neurons in the
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FIGURE 1 | Diagrammatic representation of the interconnections between the central nervous system structures implicated in stress responsiveness
and vestibular dysfunction.
guinea pig (Azzena et al., 1993; Liu et al., 1997) and an increase
in plasma AVP levels in the rat (Horii et al., 2001). Retrograde
viral tracing in the rat brain has demonstrated the presence of a
direct vestibulo-paraventricular projection (Markia et al., 2008)
and similarly a paraventricular–vestibular pathway has also been
described (Horowitz et al., 2005). Further neural pathways link-
ing the vestibular system and hypothalamus have been suggested
in models of the neuroanatomical linkage of balance and anxiety
(Balaban and Thayer, 2001) and are supported by recent behav-
ioral experiments in genetically modified mice with either abnor-
mal vestibular systems or altered levels of anxiety-like behavior
(Kalueff et al., 2008; Avni et al., 2009). In addition, monoaminer-
gic influences as part of the physiological stress response may be
further modulators of these pathways (Balaban and Thayer, 2001;
Balaban, 2002, 2004). The central release of histamine for example,
is known to stimulate ACTH prolactin and AVP, and to influence
vestibular compensation (Bergquist and Dutia, 2006; Bergquist
et al., 2006).
VESTIBULAR DYSFUNCTION ACTIVATES THE STRESS AXIS
Vestibular symptoms after unilateral vestibular deafferentation
(UVD) have been shown to activate the stress axis. Gliddon et al.
(2003) measured postoperative cortisol levels in saliva samples
from guinea pigs that underwent UVD and animals which under-
went a sham operation. Compared to preoperative levels there
was a significant increase in salivary cortisol at 10 h post surgery
in animals that underwent UVD (Gliddon et al., 2003). In a sep-
arate study, Fos expression was demonstrated in the PVN of the
hypothalamus after UVD in rats (Cameron and Dutia, 1999).
Tighilet et al. (2009) quantified CRH and AVP expression in
hypothalamic neurons in cats 1, 7, 30, and 90 days after unilateral
vestibular neurectomy (UVN). An increase was noted at 1, 7, and
30 days post UVN and which returned to normal at 90 days, indi-
cating a long-lasting activation of the HPA stress axis. Behavioral
compensation was also measured at the same time points in a sep-
arate groups of cats following UVN and a parallel was noted in the
recovery from symptoms with the expression of CRH and AVP
neurons (Tighilet et al., 2009).
By contrast,Lindsay et al. (2005) and Zhang et al. (2005) assayed
serum corticosterone at 10 h and 2 weeks post UVD in three groups
of rats either having undergone surgical UVD, sham surgery, or no
surgery (anesthetic control), and found no significant difference in
serum corticosterone between groups. Lindsay et al. (2005) addi-
tionally assessed serum corticosterone at 58 h and found that all
groups had a significant decrease in corticosterone, while Zhang
et al. (2005) found that the 10-h serum corticosterone was higher
in all groups when compared with the 2-week time-point (Lindsay
et al., 2005; Zhang et al., 2005).
In contrast to the effects of UVD, following bilateral vestibu-
lar deafferentation (BVD) in rats serum corticosterone was not
found to be elevated when compared with sham surgery at 3 weeks
(Russell et al., 2006) or 6 months (Zheng et al., 2008). Interest-
ingly, the observation that anxiety-like behavior is reduced in
animals after BVD (Zheng et al., 2008), suggests that the inter-
actions between the vestibular and limbic systems are chronically
altered after vestibular deafferentation.
An aspect which confounds the characterization of the stress
response in studies using a surgical ablation of the labyrinth in
UVL or UVN, is the stress imposed by the surgical trauma itself.
This may be very largely circumvented by using a trans-tympanic
injection of a potent local anesthetic, ropivacaine (3%, under tran-
sient general anesthesia), into the middle ear to induce a functional
inactivation of the injected ear (Figure 2). Following ropivacaine
administration the animals typically develop strong symptoms
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FIGURE 2 | Stress response evoked by the functional inactivation of
the right inner ear by trans-tympanic injection of 3% ropivacaine. (A)
ACTH and corticosterone plasma concentrations (pg/ml and ng/ml
respectively) measured by radioimmunoassay of trunk blood taken from
rats sacrificed 30 min after the onset of the symptoms of unilateral
vestibular loss. Symptom severity (spontaneous ocular nystagmus,
barrel-rolling, postural asymmetry) was estimated on a behavioral scale as
described in detail in Bergquist et al. (2008). Note sham-treated animals
(n=5) developed no symptoms and maintained low ACTH and
corticosterone levels, while ropivacaine-treated animals (n=6) developed
marked behavioral symptoms and showed ACTH and corticosterone levels
that were elevated in relation to the severity of the symptoms. (B)
Mean±SD of plasma ACTH and corticosterone concentrations in the
sham-treated group (open bars) and the ropivacaine-treated group after
functional unilateral labyrinthectomy (UL, closed bars). Bergquist, F.,
Brunton, P., and Dutia, M. B., unpublished data.
of unilateral vestibular loss within a few minutes post-injection,
which last for several hours. As shown in Figure 2, this also evokes a
marked increase in plasma ACTH and corticosterone levels 30 min
after the appearance of behavioral symptoms, indicating that the
vestibular syndrome is also a stressful condition in itself.
STRESS AXIS ACTIVATION FACILITATES VESTIBULAR COMPENSATION
In the frog, hypophysectomy delays compensation after UVL
while ACTH (4–10) administered post-UVL restores it (Flohr and
Luneburg, 1982). In the squirrel monkey ACTH (4–10) given daily
post-UVL (Igarashi et al., 1985) and following a two – staged
bilateral vestibular labyrinthectomy (Ishii and Igarashi, 1987) was
found to improve vestibular compensation. In the guinea pig
administration of methylprednisolone (Jerram et al., 1995) and
ACTH (4–10; Gilchrist et al., 1990) after UVL were found to
improve vestibular compensation while dexamethasone had no
effect (Alice et al., 1998). The synthetic ACTH (4–9) fragment
(Org 2766) was also shown to improve vestibular compensation
following UVL when administered peripherally (Gilchrist et al.,
1994) or directly into the MVN (Gilchrist et al., 1996). In the rabbit
vestibular compensation improved with dexamethasone adminis-
tration in a dose-dependent manner, and was delayed following
administration of the glucocorticoid receptor (GR) antagonist
RU38486 (Yamanaka et al., 1995b). In the rat RU38486 prevented
the increase in intrinsic electrophysiological excitability that takes
place in ipsi-lesional MVN neurons after UVL, while dexam-
ethasone administration restored it (Cameron and Dutia, 1999;
Johnston et al., 2002). The effects of dexamethasone were observed
when it was micro-injected into the ipsi-lesional cerebellar floc-
culus, indicating that the cerebellum is one site of action for GR
activation (Johnston et al., 2002).
EXCESSIVE STRESS CAN IMPAIR COMPENSATION
An optimal level of stress and GR activation seems necessary to
facilitate vestibular compensation because additional stress, in the
form of restraint applied to a compensating animal after UVD,
impedes behavioral recovery and causes de-compensation (the re-
appearance of vestibular deafferentation symptoms; Yamamoto
et al., 2000). Anecdotally it has been reported that just handling
animals after UVD would cause nystagmus to re-appear, perhaps
due to stress (Curthoys and Halmagyi, 1995). In addition to the
acute de-compensating effects of stress, it should also be noted
that neurogenesis and the survival of newly born neurons in the
hippocampus is sensitive to stress (Gould et al., 2000; Snyder et al.,
2009). Lacour and co-workers have recently provided evidence to
suggest that neurogenesis occurs in the cat MVN over a period of
time after UVN, and have proposed that this may be involved in
vestibular compensation (Tighilet et al., 2007;Dutheil et al., 2009,
2011). Stress may therefore also interact with vestibular compen-
sation by affecting the survival of new neurons in the MVN after
vestibular deafferentation, though this remains to be investigated
experimentally.
STRESS HORMONES AND NEUROSTEROIDS AFFECT MVN NEURON
EXCITATION
Animal studies suggest glucocorticoids facilitate behavioral recov-
ery during vestibular compensation by actions on the medial
vestibular nucleus (MVN) and the cerebellum (Seemungal et al.,
2001; Paterson et al., 2004; Straka et al., 2005). Prednisone has
been shown to excite neurons in the MVN of the cat (Yamanaka
et al., 1995a). In addition, neurosteroids can significantly mod-
ulate GABAergic and glutamatergic neurotransmission in the
MVN. Pregnanolone sulfate and DHEAS reduce GABA recep-
tor efficacy and thus enhance neuronal activity (Yamamoto et al.,
1998a,b), while 20-hydroxyecdysone increases GABA activity thus
inhibiting neuronal excitability (Okada et al., 1998). Pregnanolone
sulfate modulates glutamate receptors and increases MVN neu-
ron activity (Yamamoto et al., 1998b). Tetrahydrodeoxycorti-
costerone and allopregnanolone also modulate MVN neuronal
activity by their actions on GABA and AMPA/kainate receptors
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(Grassi et al., 2007), while 17 β-estradiol modulates MVN activity
by increasing excitatory glutamatergic transmission and reduc-
ing GABAergic transmission (Grassi et al., 2009a,b, 2010). These
various effects represent a potent and hitherto largely unchar-
acterized mechanism that regulates the function of the vestibu-
lar neural networks. These modulatory effects are likely to be
important both in the normal state with basal levels of cir-
culating stress hormones, and the stressed state with elevated
levels of stress hormones. In addition, such endocrine mod-
ulatory control may mediate the effects of estrogens in men-
struating women and potentially explain the increasingly appar-
ent links between the menstrual cycle and the susceptibility to
motion sickness, dizziness, and migrainous vertigo (Grassi et al.,
2009a).
STRESS AND VESTIBULAR COMPENSATION IN MAN
Dagilas et al. (2005) investigated the stress response evoked by
vestibular stimulation in healthy volunteers by measuring serum
cortisol levels at the point of maximal nystagmus while under-
going caloric stimulation. Cortisol levels were found to be signifi-
cantly elevated above resting levels,while the serum concentrations
of glutamate, glycine, and GABA were reduced (Dagilas et al.,
2005). In a preceding detailed study, Kohl (1985) demonstrated
that cross-angular rotatory vestibular stimulation potently stimu-
lated ACTH, noradrenaline, and adrenaline secretion, in a pattern
consistent with a vestibular-evoked stress response. Interestingly
while this effect was seen in all subjects, individuals with a low
susceptibility to motion sickness had higher baseline levels of
ACTH as well as a significantly larger response following rotation
(Kohl, 1985). The finding that individual stress response pro-
files may be correlated with the adaptability to stressful motion
stimuli (Kohl, 1985) also suggests that in patients with vestibular
lesions, the stress response evoked by vestibular deafferentation
may be related to their adaptability to the vestibular symptoms,
and could influence the subsequent development of vestibular
compensation.
DIMENSIONS OF THE STRESS RESPONSE IN HUMANS
While the above focuses on the physiological activation of the
HPA axis as an indicator of stress, a more holistic view in recent
literature defines stress as “experiences that are challenging emo-
tionally and physiologically” (McEwen, 2007), which normally
produce protective and adaptive effects but can also produce
deleterious outcomes in certain situations. Stress is regarded as
a mechanism of “allostasis,” the process of maintaining homeo-
static stability by active means through the production of stress
hormones, while “allostatic load or overload” results in wear
and tear on the body and brain when this system is dysfunc-
tional (McEwen, 2007). Colloquially this has been termed “good
stress and bad stress,” with the former leading to a beneficial
outcome while the latter is associated with a failure of homeo-
static recovery and the development of abnormal physiological
or psychological states. The effects of stress axis activation on
vestibular compensation demonstrated in animal studies, where
recovery is facilitated by acute stress but impeded by inappropri-
ate stress as discussed above, can be viewed as an example of such
an interaction.
STRESS RESPONSIVENESS AND COMPENSATION IN CLINICAL
PRACTICE
Vestibular stressors may present either in the form of a sin-
gle acute episode as in vestibular neuritis, a vascular event or
surgical deafferentation, or chronic repeated episodes such as in
Benign Paroxysmal Positional Vertigo (BPPV), Meniere’s disease,
or migrainous vertigo. If the process of vestibular compensation
is inadequate, the underlying dysfunction may persist and eventu-
ally present as chronic dizziness (Bronstein et al., 2010). Thus the
nature of the stress response in individual patients is likely to vary
according to the underlying dysfunction, with an acute episode
of vertigo in vestibular neuritis that gradually subsides having a
different stress response profile compared with the unpredictable
episodes in patients with Meniere’s disease or migrainous vertigo,
or the chronic dizziness of the poorly compensated patient.
While animal studies (e.g., in Figure 2) indicate that vestibular
imbalance is stressful in itself, the nature of additional stressors
that may interact to influence compensation in the human clini-
cal context remain to be determined. As discussed by Joels et al.
(2006), a normal stress response within the context of a learning
situation focuses attention and improves learning and memory,
and this may be a significant role for the vestibular-evoked stress
response in facilitating compensation. However for optimal learn-
ing to occur the stressor must occur at the same time and act on
the same neural circuits (Joels et al., 2006), so that if for example
the vestibular stress response competes with an additional stressor
such as anxiety, this may prevent vestibular compensation from
occurring optimally.
Human imaging and behavioral studies, particularly with ref-
erence to spatial memory in patients with loss of vestibular func-
tion, suggest the hippocampus may be an important center for
vestibular compensation (Brandt et al., 2005; zu Eulenburg et al.,
2010). Increased physical activity has been shown in animals to
affect brain morphology by promoting neurogenesis in the hip-
pocampus (van Praag et al., 2005) and vestibular exercises and
the promotion of physical activity in general may have similar
effects in humans. Social support also seems important to alleviate
the effects of increased allostatic load by helping humans to cope
with acute and chronic stressors (McEwen and Gianaros, 2011).
While these are the basic components of any vestibular rehabilita-
tion strategy, further research is needed to clarify the interactions
between these interventions and the stress response in relation to
compensation.
In addition, of particular relevance is that stress responsiveness
is importantly influenced by various developmental and environ-
mental factors including genetic and fetal programming and early
life stressful events, as well as varying with age and gender (de Kloet
et al., 2005; McEwen,2007; Raikkonen et al., 2011). Consequently, a
significant problem in the study of the interactions between stress
and vestibular compensation in humans is the potentially idio-
syncratic variation in stress responsiveness between patients, and
also in the same patient over time. While animal models offer the
potential to isolate and control many of these factors, the applica-
tion of findings from animal studies to the human clinical context,
and the design of effective research paradigms to understand these
interactions and their effect on brain plasticity, remains a signifi-
cant challenge for the foreseeable future. Understanding the factors
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that optimize a “good” stress response during vestibular rehabili-
tation to promote compensation, and the extent to which this is
altered in anxious patients, deserves further investigation.
ARE STEROIDS OF USE IN EARLY VESTIBULAR COMPENSATION?
A number of clinical studies have suggested a beneficial role for
steroids in the treatment of acute vestibular dysfunction. Ariyasu
et al. (1990) studied 20 patients with acute vestibular pathology
presenting with vertiginous symptoms within 72 h. Patients were
randomized into groups of 10 either receiving a tapering dose
of prednisone over 7 days, or placebo. Ninety percent of treated
patients reported a decrease in vertigo compared with 30% in
the placebo group. Patients in the placebo group that remained
symptomatic were switched to the treatment group within 24 h
and reported an improvement. All patients with a reduced caloric
response at presentation had a normal response when re-tested a
month later (Ariyasu et al., 1990).
Kitahara et al. (2003) compared outcomes in 36 vestibular
neuritis patients, half of who were prescribed 500 mg methylpred-
nisone in a tapered dose over 1 week. The average time from onset
of symptoms to treatment was 2.5 days. No significant difference
in improvement in caloric function was detected between the two
groups. Subjective outcomes were assessed using a dizziness and
unsteadiness questionnaire. Patients treated with steroids were
less handicapped due to dizziness when compared to untreated
patients (Kitahara et al., 2003).
A systematic study on 141 patients with acute onset vestibu-
lar neuritis was conducted by Strupp et al. (2004). Patients were
randomized into groups matched for age and sex (placebo – 38,
methylprednisolone – 35, valacyclovir – 33, and methylpred-
nisolone with valacyclovir – 35), within hours to days of symptom
onset. One-hundred fourteen patients completed the study. The
main outcome measure was the change in canal paresis from
pre-treatment to 12 months post-treatment. The placebo and
valacyclovir-treated groups showed an improvement in canal pare-
sis of 40 and 36% respectively, while there was an improvement of
62% in the methylprednisolone group and 59% in the methyl-
prednisolone with valacyclovir group. The authors concluded
that methylprednisolone administration improved the outcome
in acute vestibular neuritis, significantly more so than treatment
with the anti-viral valacyclovir alone (Strupp et al., 2004).
The effects of prednisolone treatment in vestibular neuritis
were investigated by Shupak et al. (2008) in 30 patients from
emergency wards and out patient departments. Patients were
randomized into a placebo group and a treatment group receiv-
ing prednisolone. ENG testing was performed within 3 days of
symptoms and only patients with a canal paresis were recruited.
Although the caloric response at 12 months showed no differ-
ence between the two groups, significantly more patients in the
prednisolone-treated group showed complete recovery at 3 and
6 months. Subjective improvement, assessed using the Dizziness
Handicap Inventory was not found to be significant (Shupak et al.,
2008).
Karlberg and Magnusson (2011) reported a study of 33 con-
secutive vestibular neuritis patients who were treated within
3 days of symptom onset with 50 mg of prednisolone daily for
5 days, tapered over the next five. Intravenous betamethasone was
administered on day 1 and 2 if nausea prevented the use of oral
medication. Caloric function at 1 year and length of hospital stay
were compared, with historic controls receiving no treatment.
Seventy percent of the treated patients recovered caloric func-
tion at 1 year compared with 34% of controls, and hospital stay
was also shorter in the group treated with steroids (Karlberg and
Magnusson, 2011).
Two recent meta-analyses have reviewed the role of steroids in
the treatment of acute vestibular dysfunction (Goudakos et al.,
2010; Fishman et al., 2011). Although both studies reviewed pre-
dominantly the same papers, there were differences in outcomes.
While Goudakos et al. use the term “vestibular neuritis,” Fishman
et al. prefer to use “idiopathic vestibular dysfunction,” suggesting
that all cases may not be virally induced and therefore inflam-
matory. This is important when considering the mechanism of
action of steroids, as in this instance their actions can include both
anti-inflammatory effects as well as effects on central pathways
involved in vestibular compensation. Each meta-analysis included
four placebo-controlled studies, of which three were common
(Ariyasu et al., 1990; Strupp et al., 2004; Shupak et al., 2008).
The outcome measure compared between studies was the com-
plete recovery or improvement in canal paresis at 12 months.
While Goudakos et al. (2010) found an improvement using a fixed
effect model, Fishman et al. (2011) found to the contrary using a
random-effects model. Attention was drawn to the relatively small
sample sizes, and differences in the clinical, methodological, and
statistical details between the studies. Nonetheless from the current
literature there is sufficient evidence to warrant further carefully
considered trials.
CHRONIC STRESS AND THE POORLY COMPENSATED PATIENT
Horii et al. (2007) reported elevated cortisol levels in dizzy patients
with neuro-otological diagnoses compared with those in a group
of patients with idiopathic dizziness, whereas plasma AVP levels
were found to be elevated in both groups (Horii et al., 2007).
Takeda et al. (1995) also reported high AVP levels in patients
during an acute attack of Meniere’s disease (Takeda et al., 1995).
van Cruijsen et al. (2005) reported significantly elevated serum
and salivary cortisol levels in Meniere’s patients compared with
healthy controls (van Cruijsen et al., 2005). Horner and Cazals
(2005) assessed cortisol and ACTH in patients with Meniere’s dis-
ease and vestibular schwannoma and compared them with levels in
patients with hemifacial spasm (as controls), and reported a strong
positive correlation between ACTH and cortisol in patients with
vestibular schwannoma and Meniere’s disease, but no such corre-
lation in patients with hemifacial spasm. This suggests a chronic
stress response in patients with persistent vestibular dysfunction
(Horner and Cazals, 2005). In a prospective longitudinal study of
the relationship between stress and the symptoms of Meniere’s
disease over a period averaging 7 months, Andersson et al. (1997)
found that dizziness was the symptom most associated with stress.
However there was no evidence that stress on preceding days was
responsible for the symptoms, suggesting that chronic stress could
be the result of symptoms rather than the cause (Andersson et al.,
1997).
In patients with chronic bilateral vestibular loss, testing with
virtual navigation tasks without self motion revealed significantly
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impaired spatial memory that was accompanied by a reduction
in hippocampal volume on MRI imaging (Brandt et al., 2005).
It is well established that patients with chronic stress undergo
hippocampal remodeling and display hippocampal atrophy with
deficits in spatial memory (McEwen, 2001; Kim and Diamond,
2002). However, vestibular inputs are also known to be very impor-
tant in the dynamic spatial tuning of hippocampal place cells
(Stackman et al., 2002; Russell et al., 2006). Thus the loss of vestibu-
lar input, as well as chronic stress, may synergize in causing the
deleterious effects on hippocampal function and total volume in
patients.
STRESS, ANXIETY, AND VESTIBULAR COMPENSATION
Eagger et al. (1992) reported on 54 patients with a history of dise-
quilibrium, objective evidence of a peripheral vestibular lesion and
current neuro-otological symptoms. Patients underwent a psy-
chiatric assessment and completed The Social Stress and Support
Interview Schedule (Jenkins et al., 1981) which explores the degree
of stress and support experienced by the patient in various facets
of everyday life. Patients with vestibular symptoms and psychiatric
morbidity were found to present with significantly increased anxi-
ety scores and experienced a greater degree of social stress (Eagger
et al., 1992).
Arousal with aversion and a lack of control are behavioral hall-
marks of the stress response (Kim and Diamond, 2002). In a
longitudinal study, Yardley et al. (1994) found that autonomic
symptoms or arousal and somatic anxiety were the best pre-
dictors of reported change in levels of vertiginous symptoms.
It was postulated that autonomic symptoms initially associated
with a vertiginous attack cause anxiety and further arousal, which
worsens the vertigo in a vicious cycle (Yardley et al., 1994).
In a cross-sectional study Eckhardt-Henn et al. (2008) found
that patients with Meniere’s and vestibular migraine had a sig-
nificantly higher risk of psychiatric disorders such as anxiety and
depression when compared with vestibular neuritis, BPPV, and
normal groups. The unpredictability and lack of control of the
attacks in Meniere’s and vestibular migraine, as opposed to the
symptoms in BPPV and vestibular neuritis, may be the likely rea-
son for the increase in psychiatric morbidity (Eckhardt-Henn et al.,
2008). Vreeburg et al. (2010) demonstrated in a cross-sectional
study using a large cohort that anxiety, in particular panic dis-
order, was associated with increased levels of cortisol (Vreeburg
et al., 2010), which reinforces the positive-feedback cycle sug-
gested above. The anatomical substrates that may mediate this
relationship between balance, anxiety, and stress have been pos-
tulated by Balaban and Thayer (2001) and Balaban (2002). In
particular the nucleus tractus solitarii have extensive relationships
with the vestibular nuclei both via direct projections and indirectly
through the parabrachial nucleus, which provides a major input
into the limbic system including the extended central amygdaloid
nucleus, the infralimbic cortex, and the hypothalamus (Balaban
and Thayer, 2001; Balaban, 2002).
However, not all patients perceive or handle stress in the
same way. Patients’ ability to habituate or cope with repeated
stress may be factors that determine outcomes. Tschan et al.
(2011) assessed resiliency (the ability to cope successfully with life
change or misfortune) and coherency (subjective perception that
enables people to manage stressful stimuli) as factors that predict
the development of somatoform vestibular dizziness in patients
1 year after admission. Their cohort included patients with BPPV,
Meniere’s, vestibular neuritis, and vestibular migraine. Patients
who developed somatoform dizziness showed significantly more
lifetime mental disorders, mental co-morbidity, and stressful life
events compared to patients who recovered normally. Signifi-
cantly, patients who recovered normally had higher scores on the
resiliency and coherency questionnaires, suggesting that they dis-
played better coping mechanisms with regard to stress. Thus the
longer-term outcomes of vestibular dysfunction or damage may be
rather idiosyncratic, likely to be influenced not only by the nature
of the associated stress response in each patient but also by the
coping mechanisms that they are able to bring into play (Tschan
et al., 2011).
CONCLUSION
The causal relationships between balance dysfunction, anxiety, and
stress need to be explored experimentally especially within the
context of vestibular compensation. An acute stress response is
known to be essential for learning and memory formation (Joels
et al., 2006) and may be an important component of vestibular
rehabilitation and compensation. However repeated exposure to
stressful stimuli or chronic stress can lead to an inhibition of brain
plasticity and lasting detrimental changes in the hippocampus,
amygdala, and prefrontal cortex (de Kloet et al., 2005; McEwen,
2007; Roozendaal et al., 2009). A range of factors influence the
responsiveness of an individual to stress, including age, sex and
genetic factors, fetal programming, and early life stressful experi-
ences, so that in the human clinical context the vestibular-evoked
stress response may be highly personalized and idiosyncratic. An
aberrant acute stress response elicited by vestibular symptoms may,
in susceptible individuals, affect the process of central compensa-
tion,possibly leading to lasting deficits. It also seems plausible from
clinical and animal studies that augmenting the acute response
with exogenous steroids may be beneficial. Further studies of the
interactions between stress and vestibular system plasticity in ani-
mals and man are necessary to fully understand their importance
in functional recovery after vestibular lesions.
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